GH Research to Present at ASCP Annual Meeting
Ticker: GHRS · Form: 6-K · Filed: May 27, 2025 · CIK: 1855129
Sentiment: neutral
Topics: conference-presentation, pipeline-update, pharmaceutical
TL;DR
GH Research presenting pipeline at ASCP meeting May 27-30.
AI Summary
GH Research PLC announced its participation in the American Society of Clinical Psychopharmacology (ASCP) Annual Meeting, held from May 27-30, 2025, in Scottsdale, Arizona. The company will present its pharmaceutical pipeline during the event.
Why It Matters
This presentation offers GH Research an opportunity to showcase its drug development progress to key opinion leaders and potential investors in the clinical psychopharmacology field.
Risk Assessment
Risk Level: low — This filing is an informational update about conference participation and does not contain material financial or operational changes.
Key Players & Entities
- GH Research PLC (company) — Registrant
- American Society of Clinical Psychopharmacology (company) — Conference Organizer
- ASCP (company) — Abbreviation for Conference Organizer
- May 27-30, 2025 (date) — Date of ASCP Annual Meeting
- Scottsdale, Arizona (location) — Location of ASCP Annual Meeting
FAQ
What is the specific session GH Research PLC will present in?
GH Research PLC will deliver a presentation as part of the Pharmaceutical Pipeline session.
When and where is the ASCP Annual Meeting taking place?
The ASCP Annual Meeting is scheduled to take place from May 27-30, 2025, in Scottsdale, Arizona.
What is the Commission File Number for this filing?
The Commission File Number is 001-40530.
What type of report is this filing?
This filing is a Form 6-K, Report of Foreign Private Issuer.
Does GH Research PLC file annual reports under Form 20-F or 40-F?
GH Research PLC files annual reports under Form 20-F.
Filing Details
This Form 6-K (Form 6-K) was filed with the SEC on May 27, 2025 regarding GH Research PLC (GHRS).